blog

Going the Extra Mile: RSG® Arrive Driver of the Month

By Elizabeth Gargill on Fri, May 3, 2019 | 2 min read

BBK’s RSG® Arrive patient travel program continues to stand out in an increasingly crowded marketplace of companies offering concierge travel and ride-hailing services. One of the reasons RSG® Arrive is in a class by itself is the dedication, commitment to care, and professionalism of its drivers. They routinely go above and beyond to ensure the comfort and care of their passengers.

Viken-Mardirossian-Square

To recognize the important role that our RSG® Arrive drivers play in enhancing the clinical trial patient experience, we will be celebrating a driver of the month, starting this month with Viken.

Topics: Patient Travel, Patient Experience

Focus 5: Amplifying the Study Voice - Capturing the Sentiment of the Study Community

By BBK Worldwide on Wed, Apr 3, 2019 | 2 min read

When examining the clinical trial experience, there’s nothing more meaningful than hearing directly from those closest to the study – patients, caregivers, physicians, and study sponsors. This year BBK launched its Study Voices initiative. Study Voices is designed to capture the sentiment of the study community at a time when the clinical research industry is growing and evolving. From innovative technology, to protocol design, and everything in between, Study Voices captures the perspectives of those closest to the clinical trial experience, offering insight that can be leveraged for action.

“Focus 5: Amplifying the Study Voice” highlights five members of the study community as they share their perspectives on the clinical trial experience.

Topics: Patient Engagement, Rare Disease, Pediatric Studies, informed consent, Patient Experience

Guest Spotlight: Annie Finstein A Message to the Medical Community

By Beth Davis Heppenstall on Tue, Feb 5, 2019 | 5 min read

Rounding out our Study Voices panel for BBK's keynote “Do Engagement Tools Live Up to Their Hype?” is panelist, Annie Finstein. She is looking forward to sharing her experience as a patient and participant in a clinical research study on February 19 at the SCOPE conference. 

Annie was diagnosed with Crohn's disease in 2000 at nine years old. After trying all available medications approved for pediatric patients at that time, she participated in a pediatric study at Massachusetts General Hospital in Boston. Now in her late 20s, she enjoys spending time at the beach, hiking, cooking and gardening at her home in Boston. Annie is committed to making a difference and connects with other patients impacted by Crohn’s disease by running half marathons with Team Challenge, the Crohn's & Colitis Foundation’s endurance training and fundraising program.Annie_Finstein

What was most rewarding to you as a participant in a clinical research study?

It was most rewarding to know that I was helping advance the treatment of Crohn’s disease for pediatric patients, and that my participation might not only help me but also other kids suffering from inflammatory bowel disease (IBD).

Topics: Patient Retention, Patient Recruitment, Patient Engagement, Patient Centricity, Patient Advocacy, Conferences, clinical trials, Patient, Patient Experience

Guest Spotlight: Dr. Linda Glaser How Do You Define Patient Engagement?

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 3 min read

We are excited to introduce one of our dynamic keynote panelists, Linda A. Glaser, MD, PhD of Coastal Biomedical Research, Inc. in Santa Monica, CA.

Linda will be sharing her site voice and insights at BBK’s Pharma15 Live! debate series at the 10th Annual SCOPE Summit on Feb 19.

While pursuing a successful career in private practice, Linda’s passion for research lead her to establish Coastal Biomedical Research, Inc. in Santa Monica. The practice specializes in clinical trials across many therapies, from diabetes to hypertension to pain management. As Medical Director, she understands the patient experience and medical site needs. As a business owner, she also understands the importance of adaptability, efficiencies and overcoming operational challenges.

What is most rewarding to you as you consider your contribution to clinical trial research?

The ability to help advance science and treat disease.

How do you define patient engagement? What does that term mean to you?

Topics: Patient Retention, Patient Recruitment, Physician Engagement, Conferences, Site Engagement, clinical research, Patient Experience, Pharma15

Guest Spotlight: Gerald Dryden Site Feasibility and Protocol Design

By Beth Davis Heppenstall on Fri, Feb 1, 2019 | 5 min read

BBK’s signature Pharma15 Live! web series is coming to the 10th Annual SCOPE Summit for Clinical Ops Executives. On February 19, Bonnie A. Brescia, BBK’s founding principal, will moderate a panel during the conference’s plenary keynote program on the topic of “Do Engagement Tools Live Up to Their Hype?” 

We are pleased to introduce one of our panelists, Gerald Wayne Dryden, Jr., MD, PhD, MSPH, MSc of University of Louisville, Kentucky.

Dr. Gerald Dryden

Dr. Gerald “Tad” Dryden is Professor of Medicine and Director of the Inflammatory Bowel Disease Program in the Division of Gastroenterology at the University of Louisville in Louisville, KY.  He earned his MD at the University of Kentucky College of Medicine in Lexington, KY, and completed his internal medicine internship and residency at the Naval Medical Center in Portsmouth, VA. He then completed his gastroenterology fellowship at the Naval Medical Center in San Diego, CA.  During his tenure at the University of Louisville, he earned a Master of Science in Public Health, a Master of Science in Microbiology and Immunology, and a PhD in Microbiology and Immunology. Dr. Dryden’s research interests include developing new therapies from botanical sources and new medical devices to improve endoscopic care.

What is most rewarding to you as you consider your contribution to clinical trial research?

It is very rewarding when I am involved with a drug from the ground up -- seeing research patients benefit from the drug, then eventually being able to prescribe it to my clinic patients.

Topics: Patient Retention, Patient Recruitment, Physician Referrals, Patient Engagement, Site Support, Patient, Patient Experience, Pharma15

The Impact a Travel Program Can Have on Your Patient Recruitment and Engagement Success

By BBK Worldwide on Mon, Jan 7, 2019 | 2 min read

When it comes to the benefits travel programs offer in support of clinical trials, opinions are varied. In a recent article published in International Clinical Trials, BBK’s Hannu Koski and Rob Laurens present compelling data with industry insights. “Talking Travel” looks at the appeal travel assistance programs have from the patients’ perspective.

Topics: BBK Worldwide, Patient Retention, Patient Recruitment, Trends, Patient Travel, Patient, Patient Experience, Patient Data

Pharma15 Live! Special: The Caregiver's Caregiver

By Danielle Frate on Tue, Dec 4, 2018 | 2 min read

So much of the focus of clinical trial participation is on the patient and reducing site staff burden. But sometimes we forget about the role of the caregiver. After all, it is usually the caregiver driving the patient to their appointments, managing medication schedules, taking notes at doctor’s appointments, and much more. It makes you wonder: who is the caregiver’s caregiver? Enter Zaggo, a non-profit organization that provides the tools caregivers need to take care of their loved one as effectively and efficiently as possible.

Zaggo was born out of the experience of its founder and president, Roberta Carson, after she was thrust into the role of caregiver for her son Zachary during his 27-month battle with pediatric brain cancer.

Topics: Patient Experience, Pharma15, Most Viewed

Uber, Lyft, and Emergency Care: CEO of BBK Worldwide, Joan F. Bachenheimer Responds to The New York Times

By Joan F. Bachenheimer on Thu, Oct 18, 2018 | 4 min read

You might have seen an article in the October 1 issue of The New York Times, titled “Uber, Lyft and the Urgency of Saving Money on Ambulances,” by Austin Frakt. The article pushed for alternative modes of transportation in medical situations – such as Uber and Lyft – as cost-saving measures.

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, wrote a strong response to the article, which has been submitted to the Times as a Letter to the Editor. We would love to hear your thoughts on possible use of ride-sharing apps like Uber or Lyft for emergency services.

 

Topics: Patient Retention, Patient Engagement, Patient Travel, Patient Experience

DPharm 2018: Who Owns Patient Data, and Who’s Just Visiting?

By BBK Worldwide on Wed, Oct 10, 2018 | 1 min read

What does patient data ownership actually mean? According to Craig Lipset, head of clinical innovation at Pfizer and DPharm 2018 co-chair, that is still an open question. Pharma15 Live! chatted with him about it at the DPharm 2018 conference.

Topics: Disruptive Innovation, Conferences, clinical research, clinical trials, Patient Experience, Pharma15, Most Viewed, Patient Data

Maximizing Digital Patient Engagement: A Four Step Process

By BBK Worldwide on Thu, Aug 2, 2018 | 1 min read

The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.

Topics: Patient Engagement, digital health, Patient Experience, Pharma15, Vlog

 
Subscribe To Our Blog